SCHEMBL24725974

SCHEMBL24725974

c1ccc(-c2cccc3cccc(-c4ccc(Nc5ccc(-c6ccccc6-n6c7ccccc7c7ccccc76)cc5)cc4)c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.37
ATM Q13315 3/20 0.37
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 5/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPK1 P28482 2/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM1A O60341 1/20 0.34
RAB9A P51151 1/20 0.34
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
CDC25B P30305 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25691098 0.92 ALDH1A1 (0.35) PDE6DATMKDM4EL3MBTL1ALDH1A1
SCHEMBL25688796 0.91 ATM (0.45) PDE6DATMKDM4EL3MBTL1ALDH1A1
SCHEMBL25686545 0.90 ALDH1A1 (0.41) PDE6DATMKDM4EL3MBTL1ALDH1A1
SCHEMBL20009757 0.89 L3MBTL1 (0.43) ATMKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL21188095 0.89 L3MBTL1 (0.43) ATMKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL29407291 0.89 L3MBTL1 (0.43) ATMKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL24173705 0.87 L3MBTL1 (0.44) ATMKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL31229634 0.87 L3MBTL1 (0.44) ATMKDM4EL3MBTL1ALDH1A1MEN1
SCHEMBL25972773 0.86 PDE6D (0.39) PDE6DATMKDM4EL3MBTL1ALDH1A1
SCHEMBL24725940 0.86 KDM4E (0.41) PDE6DATMKDM4EL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
WO-2022199449-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING SAME, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2022-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189638-A1 ORGANIC COMPOUND AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS THEREOF AOX1, PIEZO1, CYP2E1 PDE6D 3953/4885ATM 2438/4885KDM4E 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.